Advanced search

Stefan Feuerstein is currently a Non-Independent Director at Greenrise Global Brands, Inc., a Director at Taiga Atlas Plc, and a Managing Director at AMP Alternative Medical Products GmbH.
Previously, he held positions as a Managing Director at Industrial Investment Council GmbH, Bt Biofuels Europe GmbH, and Thüringer Landwirtschafts Forderungsgesellschaft.

Stefan Feuerstein is a businessperson who has been the head of 11 different companies. Mr. Feuerstein occupies the position of Chairman of Zur Rose Group AG, Chairman-Supervisory Board for Kühnl + Schmidt Architekten AG, Chairman at Kuhnl & Schmidt Architekten AG and Chairman for Evan Management AG. Stefan Feuerstein is also on the board of ElectronicPartner Handel SE, UNIMO Real Estate Management AG and Haubrich Holding SE. In his past career he held the position of Chairman of Al Faisaliah Group Holding Co., Chairman-Supervisory Board of NORDWEST Handel AG, Chairman-Supervisory Board for EMD AG, Chairman-Supervisory Board of Markant Syntrade Schweiz AG, Chief Executive Officer & Executive Director at MARKANT AG, Managing Director at MFC Capital Partners AG, Chief Operating Officer at Mansfelder Metals Ltd., Second Vice Chairman-Supervisory Board at WMF AG and Member-Management Board at METRO AG.

Andrew Feuerstein currently works as a Director for the Ovarian Cancer Research Fund, Inc.

Seth D.
Feuerstein founded Oui Therapeutics Inc, where he is working as Chief Executive Officer.
Dr. Feuerstein also currently works at eMindful, Inc., as Director, HistoRx, Inc., as Director, Mental Health Association of New York City, Inc., as Director, Lyssn.io, Inc., as Director, Psyence Biomedical Ltd., as Independent Director from 2024, Athyrium Capital Management (Private Equity), as Senior Advisor, Vita Health Services PLLC, as Chief Executive & Financial Officer, and Athyrium Capital Management LP, as Senior Advisor.
Dr. Feuerstein also formerly worked at Carigent Therapeutics, Inc., as President, Ocre Ltd, as Principal, Yale University, as Principal, Maven Capital LLC, as Principal, and Elm Street Advisors LLC, as Principal in 2007.
Dr. Feuerstein received his undergraduate degree from Cornell University and graduate degree and doctorate degree from New York University.

Harry A.
Feuerstein is currently a Director at Merryck & Co. Americas LLC and Merryck & Co. Ltd.
He was previously a Director at TRX, Inc. from 2005 to 2008, Chief Operating Officer at Hercules Capital, Inc. in 2014, and Chief Financial Officer at Siemens One, Inc. He holds an MBA from Hofstra University and an undergraduate degree from Washington & Lee University.

Leigh Feuerstein is the founder of Halen Brands, Inc. which was founded in 2015, where he holds the title of Co-Chief Executive Officer.
He currently holds the position of Director at Food Allergy Research & Education, Inc. and at L'Auberge de Sonoma Resort Fund LLC.
Mr. Feuerstein previously held the position of Independent Director at Lat33 Capital, Inc.